investment

Study underway in Montreal to estimate how many children and teens have been infected with SARS-CoV-2

Today, Canada’s COVID-19 Immunity Task Force (CITF) announces its support for a research project that will estimate how many children and teens in Montreal have been infected with SARS-CoV-2, the virus that causes COVID-19. This $720,000 investment will allow us to better understand how much virus transmission has occurred to children and teens, and [...]

2021-02-26T10:40:25-05:00October 20, 2020|Media Releases|
Read More

Investing in our most vulnerable: The COVID-19 Immunity Task Force funds comprehensive new SARS-CoV-2 seroprevalence study focused on aging Canadians

Canada's COVID-19 Immunity Task Force (CITF) announces its support for a new SARS-CoV-2 seroprevalence study focused on aging Canadians, a population that has been shown to be at greatest risk for severe outcomes from COVID-19 disease.  This $4 million investment will be carried out by the Canadian Longitudinal Study on Aging (CLSA), a national platform for research [...]

2021-02-26T10:42:09-05:00October 1, 2020|Media Releases|
Read More
COVID-19 Immunity Task Force

The COVID-19 Immunity Task Force Secretariat is housed at the McGill University School of Population and Global Health.

The views expressed herein do not necessarily represent the views of the Public Health Agency of Canada.

Go to Top